Oncologic outcomes after minimally invasive surgery for cT1 renal masses: a comprehensive review

Curr Opin Urol. 2018 Mar;28(2):132-138. doi: 10.1097/MOU.0000000000000477.

Abstract

Purpose of review: To evaluate current literature reporting oncologic outcomes after robot-assisted partial nephrectomy (RAPN) and laparoscopic partial nephrectomy (LPN).

Recent findings: Recently, there have been published first mid-term results after RAPN (5 years). To date, there are no randomized trials to guide decision-making regarding LPN or robotic partial nephrectomy (RPN), and such trials are unlikely to be forthcoming, given the rapid adoption of RAPN worldwide. We performed a literature search according to Cochrane guidelines up to 1 September 2017, including studies that had more than 40 months of oncologic follow-up.

Summary: A total of 2933 patients were included from 14 studies (1498 RAPN, 1525 LPN). RAPN had similar mid-term (5 years) oncologic outcomes as LPN. Large collaborative efforts are still necessary to provide solid long-term oncologic outcomes of open, laparoscopic, and RPN.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Carcinoma, Renal Cell / mortality
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / surgery*
  • Clinical Decision-Making
  • Kidney Neoplasms / mortality
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery*
  • Laparoscopy / adverse effects
  • Laparoscopy / instrumentation
  • Laparoscopy / methods*
  • Length of Stay / statistics & numerical data
  • Margins of Excision
  • Neoplasm Recurrence, Local / epidemiology*
  • Neoplasm Recurrence, Local / prevention & control
  • Neoplasm Staging
  • Nephrectomy / adverse effects
  • Nephrectomy / instrumentation
  • Nephrectomy / methods*
  • Patient Selection
  • Robotic Surgical Procedures / instrumentation
  • Robotic Surgical Procedures / methods*
  • Survival Analysis
  • Treatment Outcome